Infinex to Pause Yaprun After Season One to Implement Partial Improvements and Bot Nerfs
Foresight News reports that cross-chain DeFi aggregation platform Infinex has announced it will pause Yaprun after the end of the first season to implement certain improvements and anti-bot measures. Infinex explained, "The fundamental issue Infinex currently faces is that accounts following Infinex updates are overwhelmed by fake interactions. When Kaito's smart fan metric soared to over 100,000 accounts—many of which have questionable authenticity—we realized the system had collapsed. Infinex is more concerned about the 3,000 to 5,000 verified real users whose contributions are crucial to Infinex's narrative. Once Infinex addresses these challenges, the second season will return."
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Starbucks (SBUX.US) officially refutes rumors: clearly denies acquiring Chipotle (CMG.US), focuses on "Back to Starbucks" transformation strategy
Starbucks publicly clarified on Monday that the company has not acquired Chipotle Mexican Grill, putting an end to the previous acquisition rumors.
BlackRock increases allocation to short-term US Treasuries and lowers US stocks: "Rate hike bets have gone too far," high yields should be prioritized
BlackRock has turned bullish on U.S. Treasury bonds for the first time in six years, upgrading short-term bonds to overweight and downgrading U.S. equities to neutral, stating that rate hike expectations are excessive and it is time to lock in yields.

AstraZeneca (AZN.US) Relizumab's new indication is expected to be included in priority review
Relizumab is a blockbuster product under AstraZeneca, with global sales projected to reach 4.718 billions USD in 2025 (YOY +20.23%).
